New development in Valley fever vaccine for companion animalsOctober 15, 2018A novel Valley fever sub-unit vaccine for companion animals has been found by Mazen Animal Health to reduce the burden of coccidioides—the fungus that can cause Valley fever—in mice.
SPONSORED CONTENTHow can you help new pet owners keep their new dogs protected?See why new dog owners and their pets can benefit from simple triple protection in one monthly chew. + See the Difference
Ongoing quest for immunityJune 12, 2018Vaccines are a staple in preventive medicine, and every year more are added to the arsenal. Here’s what’s going on now in this sector of the profession.
UA researchers get $4.8 million to develop valley fever vaccineSeptember 6, 2017The University of Arizona's (UA) efforts to prevent valley fever in dogs received a boost in the way of a $4.8 million, four-year grant from the National Institutes of Health, providing the funding necessary to get the disease's delta-CPS1 vaccine to market, according to John Galgiani, MD, director of the UA Valley Fever Center for Excellence and principal investigator of the NIH grant. The vaccine, which could hit the market as soon as five years from now, will be developed for dogs first, but the end goal is to use it in humans, as well, according to Dr. Galgiani. There is currently no prevention or cure for valley fever, which is potentially deadly in both humans and dogs. Every year, an estimated 30,000 people and 60,000 dogs in Arizona get sick from valley fever, also known as coccidioidomycosis, according to UA. The cocci fungus that causes the disease is found mainly in dusty areas of Arizona and California, and it contributed to the deaths of 54 people in Arizona last year, state officials said. Treatment for valley fever is expensive: $4 to $6 per-day meds, blood tests, and additional …
